Therapy Areas: Autoimmune
Formula Pharmaceuticals Initiates First Clinical Trial of Allogeneic CIK-CAR Cancer Immunotherapy
19 September 2017 - - Berwyn, Pennsylvania-based immuno-oncology-focused Formula Pharmaceuticals, Inc. has opened the first clinical trial for allogeneic Cytokine Induced Killer (C.I.K.) cell-based Ch...
European Medicines Agency adopts positive opinion for Boehringer Ingelheim's Cyltezo Marketing Authorisation
19 September 2017 - The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the Marketing Authorisation Application f...
CSL Behring wins US FDA approval for Privigen for the treatment of adults with chronic inflammatory demyelinating polyneuropathy
15 September 2017 - Biotherapeutics comany CSL Behring disclosed on Thursday the receipt of US Food and Drug Administration's (FDA) approval for Privigen [Immune Globulin Intravenous (Human), 10%...
Global Biopharmaceutical Contract Manufacturing Market to Reach USD 15,467.8m by 2027, Future Market Insights Forecasts
13 September 2017 - - The global biopharmaceutical contract manufacturing market is estimated to be valued at USD 5,625m by the end of 2017 and this is expected to increase to USD 15,467.8m ...
Manning Named to Palatin Technologies Board of Directors
12 September 2017 - - Anthony M. Manning, Ph.D. has been appointed US-based biopharmaceutical company Palatin Technologies, Inc.'s (NYSE MKT: PTN) board of directors, the company said on Tue...
ImmusanT Data Showing Increased Cytokine Levels after Gluten in Celiac Disease Provide Potential Basis for a Novel Diagnostic
12 September 2017 - - US-based celiac disease specialist ImmusanT, Inc. has presented data demonstrating the immunologic basis for the early clinical effects of gluten in celiac disease in two poster ...